Jonathan Avery is an American addiction psychiatrist and academic based at Weill Cornell Medical College.[1] At Weill Cornell,he serves as Vice Chair for Addiction Psychiatry and holds the endowed Stephen P. Tobin and Dr. Arnold M. Cooper Professorship in Consultation Liaison Psychiatry.[2] He is also the medical director of the NBA/NBPA Anti-Drug Program.[2][3]
He founded the Weill Cornell / New York-Presbyterian Program for Substance Use and Stigma of Addiction. The program was launched in 2019 and focuses on reducing stigma in medical settings,as well as improving intervention strategies.[4] Since 2023,he has been the medical director of the NBA/NBPA Anti-Drug Program.
Research and advocacy
Avery's research topics include clinician attitudes toward patients with substance use disorders,adoption of buprenorphine,and stigma-reduction interventions for health care professionals and trainees.[2] He has authored or edited texts such as Co-occurring Mental Illness and Substance Use Disorders:A Guide to Diagnosis and Treatment[5] and The Stigma of Addiction:An Essential Guide.[6]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.